Funding Rounds
InnoSkel

InnoSkel Series A (2020, $24M)

InnoSkel

Platform biotechnology company focused on developing therapies for rare skeletal diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $24.41M

Raised Date: 2020-01-01